Gary L. Feiss is a clinical research expert with over 20 years of global experience in the research and development field, with emphasis in clinical research and regulatory affairs for drugs, diagnostics and medical devices. His therapeutic experience includes infectious disease, dermatology, respiratory, cardiovascular, neurology, vaccines, oncology, and surgical areas in drugs, in-vitro diagnostics, and companion diagnostics. Mr. Feiss joined Cutanea Life Sciences as Vice President, Clinical Operations in April of 2012. Prior to joining CLS, Mr. Feiss served as Vice President, Clinical Development and Regulatory Affairs at Saladax Biomedical, Inc., in Bethlehem, PA. In addition to this role, Mr. Feiss has worked in other clinical capacities, including, Director, Clinical Trials, at OraSure Technologies, Inc., Associate VP Head, Clinical Development and Regulatory Affairs at Dermik Laboratories, a division of Sanofi-Aventis, Vice President, Project Management and Regulatory Affairs at Covalent Group, Inc. Mr. Feiss received his Master of Science in Exercise and Sport Sciences from the University of Arizona, Tucson, AZ, as well as his Bachelor of Science in Health and Physical Education from Penn State University, University Park, PA.